Cited by CrossRef (2)

  1. Moeka Nakashima. Caveolae with serotonin and NMDA receptors as promising targets for the treatment of Alzheimer’s disease. Int J Physiol Pathophysiol Pharmacol 2024;16:96
    https://doi.org/10.62347/MTWV3745
  2. Moeka Nakashima, Naoko Suga, Sayuri Yoshikawa, Satoru Matsuda. Caveolae with GLP-1 and NMDA Receptors as Crossfire Points for the Innovative Treatment of Cognitive Dysfunction Associated with Neurodegenerative Diseases. Molecules 2024;29:3922
    https://doi.org/10.3390/molecules29163922
© The Korean Journal of Physiology & Pharmacology. / Powered by INFOrang Co., Ltd